Logo image of ATHR

AETHER HOLDINGS INC (ATHR) Stock Fundamental Analysis

NASDAQ:ATHR - Nasdaq - US00809R2022 - Common Stock - Currency: USD

9  -0.2 (-2.17%)

Fundamental Rating

1

Overall ATHR gets a fundamental rating of 1 out of 10. We evaluated ATHR against 237 industry peers in the Capital Markets industry. ATHR may be in some trouble as it scores bad on both profitability and health. ATHR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ATHR has reported negative net income.
ATHR had a negative operating cash flow in the past year.
ATHR Yearly Net Income VS EBIT VS OCF VS FCFATHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 200K -200K -400K -600K -800K

1.2 Ratios

The Return On Assets of ATHR (-366.97%) is worse than 97.89% of its industry peers.
Industry RankSector Rank
ROA -366.97%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATHR Yearly ROA, ROE, ROICATHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -200 -400 -600 -800

1.3 Margins

The Gross Margin of ATHR (68.73%) is better than 74.68% of its industry peers.
The Profit Margin and Operating Margin are not available for ATHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATHR Yearly Profit, Operating, Gross MarginsATHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for ATHR remains at a similar level compared to 1 year ago.
There is no outstanding debt for ATHR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ATHR Yearly Shares OutstandingATHR Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2M 4M 6M 8M 10M
ATHR Yearly Total Debt VS Total AssetsATHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200K 400K 600K

2.2 Solvency

ATHR has an Altman-Z score of 48.55. This indicates that ATHR is financially healthy and has little risk of bankruptcy at the moment.
ATHR's Altman-Z score of 48.55 is amongst the best of the industry. ATHR outperforms 99.16% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 48.55
ROIC/WACCN/A
WACCN/A
ATHR Yearly LT Debt VS Equity VS FCFATHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 200K -200K -400K -600K -800K

2.3 Liquidity

A Current Ratio of 0.38 indicates that ATHR may have some problems paying its short term obligations.
ATHR has a worse Current ratio (0.38) than 81.43% of its industry peers.
ATHR has a Quick Ratio of 0.38. This is a bad value and indicates that ATHR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.38, ATHR is not doing good in the industry: 81.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
ATHR Yearly Current Assets VS Current LiabilitesATHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200K 400K 600K

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ATHR have decreased strongly by -239.32% in the last year.
Looking at the last year, ATHR shows a decrease in Revenue. The Revenue has decreased by -7.42% in the last year.
EPS 1Y (TTM)-239.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-126.03%
Revenue 1Y (TTM)-7.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATHR Yearly Revenue VS EstimatesATHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ATHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATHR Price Earnings VS Forward Price EarningsATHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATHR Per share dataATHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATHR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AETHER HOLDINGS INC

NASDAQ:ATHR (8/4/2025, 2:08:34 PM)

9

-0.2 (-2.17%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap108.90M
AnalystsN/A
Price TargetN/A
Short Float %3.45%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 77.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.12
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -366.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.73%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover3.82
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z 48.55
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-239.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-126.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-217.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-516.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-516.09%
OCF growth 3YN/A
OCF growth 5YN/A